
BrightSpring Health Services (BTSG) is back in focus after management twice raised its 2026 outlook, attributing the change to firm demand, improved profitability, and smoother th…
BTSG is down 2.05% today. Volume is 1.93M vs a 30-day average of 2.33M (0.83x).
BrightSpring Health Services, I is scheduled to report earnings Fri, Oct 30, 2026 · before open. Analysts expect EPS of $0.48 on revenue of about $3.95B. Stocks often move sharply on earnings day.

BrightSpring Health Services (BTSG) is back in focus after management twice raised its 2026 outlook, attributing the change to firm demand, improved profitability, and smoother th…

BrightSpring's shares surge 67.3% year to date, fueled by strong pharmacy and provider growth, improving profitability and a brighter 2026 outlook.

BrightSpring's new oncology distribution wins also grow their addressable market, which is why drug adoption is vital going forward. Learn why BTSG stock is a buy.

BrightSpring Health Services (BTSG) is rated Hold as robust revenue and EBITDA growth are balanced by margin pressures and valuation concerns.